Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 11—November 2013
Dispatch

Increased Incidence of Campylobacter spp. Infection and High Rates among Children, Israel

Miriam WeinbergerComments to Author , Larisa Lerner, Lea Valinsky, Jacob Moran-Gilad, Israel Nissan, Vered Agmon, and Chava Peretz
Author affiliations: Assaf Harofeh Medical Center, Zerifin, Israel (M. Weinberger); Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel (M. Weinberger, C. Peretz); Israel Ministry of Health, Jerusalem, Israel (L. Lerman, L. Valinsky, I. Nissan, V. Agmon); Israel Ministry of Health Public Health Services, Jerusalem (J. Moran-Gilad)

Main Article

Table

Incidence of Campylobacter spp. infection by study period, sex, and age group, Israel 1999–2010

Campylobacter species Incidence rate ratio (95% CI)
Full study period, 1999–2010 Study period I, 1999–2006 Study period II, 2007–2010
All Campylobacter spp.
Annual trend* 1.10 (1.08–1.12) 1.08 (1.05–1.12) 1.19 (1.12–1.25)
Male sex† 1.36 (1.22–1.52) 1.37 (1.18–1.60) 1.35 (1.21–1.51)
Age group, y‡
  0–<2 26.27 (18.68–36.96) 29.96 (18.96–47.33) 22.81 (13.49–38.59)
  2–<10 5.50 (3.91–7.75) 5.86 (3.70- 9.28) 5.17 (3.05–8.75)
  10–<30 2.34 (1.57–3.50) 2.29 (1.33–3.92) 2.40 (1.30–4.43)
  50–<70 1.42 (0.92–2.20) 1.51 (0.85–2.70) 1.33 (0.67–2.63)
  >70
 1.81 (1.19–2.74)
 1.81 (1.03- 3.16)
 1.81 (0.95–3.43)
C. jejuni
Annual trend* 1.10 (1.08- 1.12) 1.09 (1.06–1.12) 1.19 (1.12–1.26)
Male sex† 1.39 (1.25–1.54) 1.40 (1.23–1.61) 1.37 (1.21–1.55)
Age group, y‡
  0–<2 28.42 (19.96–40.46) 31.42 (19.89–49.62) 25.45 (14.36–45.09
  2–<10 6.04 (4.24–8.61) 6.29 (3.98–9.95) 5.78 (3.26–10.26)
  10–<30 2.50 (1.66–3.77) 2.42 (1.42- 4.13) 2.58 (1.33- 4.99)
  50–<70 1.42 (0.90–2.23) 1.40 (0.86- 2.74) 1.30 (0.62–2.75)
  >70
 1.70 (1.09–2.63)
 1.73 (0.99- 3.05)
 1.66 (0.81–3.37)
C. coli
Annual trend* 1.11 (1.08–1.13) 1.07 (1.01–1.12) 1.17 (1.12- 1.23)
Male sex† 1.28 (1.10–1.50) 1.27 (0.98–1.65) 1.29 (1.15–1.45)
Age group, y ‡
  0–<2 20.16 (14.04–28.94) 25.57 (14.81–44.14) 15.86 (10.12–24.85)
  2–<10 3.99 (2.77–5.73) 4.53 (2.61- 7.86) 3.55 (2.26–5.57)
  10–<30 1.91 (1.24–2.95) 1.87 (0.97- 3.64) 1.94 (1.13–3.31)
  50–<70 1.42 (0.90–2.25) 1.44 (0.72–2.90) 1.40 (0.79–2.48)
  >70 2.09 (1.36–3.22) 2.03 (1.06- 3.91) 2.15 (1.27–3.64)

*Per year, adjusted for study years.
†Reference: female
‡Reference: 30–<50 y age group.

Main Article

Page created: October 31, 2013
Page updated: October 31, 2013
Page reviewed: October 31, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external